Research Grants

Research Grants

The leading funder of multiple myeloma research

As the leading funder of multiple myeloma research, the MMRF has supported more than 350 research grants at over 135 institutions worldwide. The MMRF supports innovative research efforts in the most promising areas of multiple myeloma research through several grant-making programs. We remain committed to supporting researchers who have more than five years experience in blood cancer research as well as attracting younger scientists to enter the myeloma research field to build the next generation of scientific leaders.

Grant Opportunities:

Significant advances in our understanding of the pathophysiology and molecular biology involved in multiple myeloma have identified numerous putative molecular targets for therapeutic intervention. The MMRF welcomes proposals on any and all multiple myeloma related topics to the traditional Research Grant Award programs. Applications are accepted from non-profit institutions and universities in the United States and internationally. Program guidelines and applications are available approximately 6-8 weeks prior to the submission deadline.

Senior Research Awards:

We will not be offering Senior Research Awards in 2016.

Research Fellow Awards:

For researchers who hold a Ph.D., M.D. or equivalent degree at the post-doctorate, clinical fellow or assistant professor levels who are beginning studies in the multiple myeloma field under the supervision of a research mentor or sponsor. Applicants may request up to $75,000 for one year. Application deadline: April 26, 2016 at 5PM EST

2016 Research Fellows applicant guidelines.

Search Research Grants

Year Awarded
Type
Investigator

A Combination Strategy Targeting The Bcl-2 Family In Multiple Myeloma

Virginia Commonwealth University
Validation of Novel Combinations
Investigator: Steven Grant
Amount: $100,000
Year awarded: 2007

Adoptive Immunotherapy With Donor Myeloma-specific T Cells

University of Texas
Senior Research Award
Investigator: Larry Kwak
Amount: $100,000
Year awarded: 2006

An Integrated Study Of Proteostasis Against Multiple Myeloma

Fondazione Centro San Raffaele del Monte Tabor
Senior Research Award
Investigator: Simone Cenci
Amount: $200,000
Year awarded: 2010

A Novel Aurora Kinase Inhibitor, AT9283, And Lenalidomide In MM

Dana Farber Cancer Institute
Research Fellow Award
Investigator: Loredana Santo
Amount: $75,000
Year awarded: 2010

Anti-Pleiotrophin-Mediated Therapy For The Treament Of Multple Myeloma

The Institute for Myeloma and Bone Cancer Research
Validation of Novel Combinations
Investigator: James Berenson
Amount: $100,000
Year awarded: 2006

Anti-b2M Monoclonal Antibodies As Therapeutic Agent For Myeloma

University of Texas
Senior Research Award
Investigator: Qing Yi
Amount: $200,000
Year awarded: 2008

A Proteomic Approach To Discover Novel Monoclonal Antibody Targets

The Chancellor, Masters, and Scholars of the University of Cambridge
Senior Research Award
Investigator: Michael Chapman
Amount: $200,000
Year awarded: 2014

A Systems Approach For Identifying Possible Drug Combinations In Myeloma

National Cancer Institute
Research Fellow Award
Investigator: John Simmons
Amount: $75,000
Year awarded: 2014

A Transgenic Model Of Multiple Myeloma

University of Pittsburgh
Animal Model Development Award
Investigator: PREET CHAUDHARY
Amount: $200,000
Year awarded: 2007

Beta 1 Integrin Inhibitory Peptides: Novel Agents For The Treatment Of MM

Moffitt Cancer Center and Research Institute
Senior Research Award
Investigator: Lori Hazlehurst
Amount: $200,000
Year awarded: 2008

Biomarker Discovery And Validation In Multiple Myeloma Cells Using Multiple Proteomic Platforms.2007

Indiana University Indianapolis
Proteomics Award
Investigator: Mu Wang
Amount: $750,000
Year awarded: 2007

Cell Cycle Based Combination Therapy For Multiple Myeloma

Cornell University
Senior Research Award
Investigator: Selina Chen-Kiang
Amount: $200,000
Year awarded: 2007

Cereblon Control Of IMiD Function

Mayo Clinic Scottsdale
Senior Research Award
Investigator: Alexander Stewart
Amount: $200,000
Year awarded: 2011

Characterization Of Phospho-Protein Networks In Myeloma

University Health Network
Senior Research Award
Investigator: Suzanne Trudel
Amount: $100,000
Year awarded: 2006

Characterizing Lethal And Drug-sensitizing Kinome Targets In Myeloma

Mayo Clinic Scottsdale
Research Fellow Award
Investigator: Rodger Tiedemann
Amount: $75,000
Year awarded: 2007

Chimeric Antigen Receptor Modified T Cells For Multiple Myeloma

Memorial Sloane-Kettering Cancer Center
Research Fellow Award
Investigator: Eric Smith
Amount: $75,000
Year awarded: 2014

Chromatin Writers, Readers And Erasers In Multiple Myeloma

Northwestern University Chicago
Epigenetics Program Project Grant
Investigator: Jonathan Licht
Amount: $1,500,000
Year awarded: 2013

Combination Therapies Targeting Proteasome, Mitochondria And NF-kappa B

Dana Farber Cancer Institute
Validation of Novel Combinations
Investigator: Dharminder Chauhan
Amount: $100,000
Year awarded: 2006

Combination Of PARP And Proteasome Inhibitors In Multiple Myeloma

University of Calgary
Senior Research Award
Investigator: Nizar Bahlis
Amount: $200,000
Year awarded: 2011

Combination Of Drugs And Radiation For Improved Therapy Of Multiple Myeloma

Mayo Clinic Rochester
Senior Research Award
Investigator: Apollina Goel
Amount: $100,000
Year awarded: 2006

Combined Therapy Of Bortezomib And BMS-345541 In A Myeloma Mouse Model

Moffitt Cancer Center and Research Institute
Validation of Novel Combinations
Investigator: Zhi-Wei Li
Amount: $99,936
Year awarded: 2006

Combining IGF-1R And HDAC Inhibitors In MM Models In Vitro And In Vivo

Vrije Universiteit Brussel
Validation of Novel Combinations
Investigator: Karin Vanderkerken
Amount: $100,000
Year awarded: 2007

Combining Tumor Vaccines With Adoptive Immunotherapy In Myeloma

Johns Hopkins University
Validation of Novel Combinations
Investigator: Ivan Borrello
Amount: $100,000
Year awarded: 2006

Comparative Oncogenomic To Identify Myeloma Progression Events

Mayo Clinic Scottsdale
Senior Research Award
Investigator: Marta Chesi
Amount: $200,000
Year awarded: 2008

Consequences Of KDM6A/UTX Loss In Multiple Myeloma

Translational Genomics Research Institute
Target Credentialing Award
Investigator: Jonathan Keats
Amount: $250,000
Year awarded: 2010

Define CKS1B Signaling Pathways In Myeloma: Therapeutic Implication

University of Arkansas
Senior Research Award
Investigator: Fenghuang Zhan
Amount: $200,000
Year awarded: 2008

Defining Role Of Wnt Signaling In Multiple Myeloma: Therapeutic Implication

University of Arkansas
Senior Research Award
Investigator: Ya-Wei Qiang
Amount: $96,821
Year awarded: 2006

Delineation Of Differential Role Of Canonical & Non-canonical NF-kB Pathway

Dana Farber Cancer Institute
Senior Research Award
Investigator: Teru Hideshima
Amount: $200,000
Year awarded: 2007

Determining The Mutational Profile Of Circulting Multiple Myeloma Cells

Dana Farber Cancer Institute
Research Fellow Award
Investigator: Jens Lohr
Amount: $75,000
Year awarded: 2014

Determining The Role Of The Histone Demethylase Gene JMJD1C In Myeloma

The Translational Genomics Research Institute
Research Fellow Award
Investigator: Bodour Salhia
Amount: $75,000
Year awarded: 2011

Development Of Cyclin D2 Inhibitors For Treatment Of Multiple Myeloma

Mayo Clinic Scottsdale
Senior Research Award
Investigator: Alexander Stewart
Amount: $100,000
Year awarded: 2006

Development Of Novel Types Of Proteasome Inhibitors That Regulate Substrate

Harvard Medical School
Senior Research Award
Investigator: Alfred Goldberg
Amount: $200,000
Year awarded: 2008

Development Of Allosteric Proteasome Inhibitors For The Treatment Of MM

Michigan State University
Senior Research Award
Investigator: Jetze Tepe
Amount: $200,000
Year awarded: 2010

Development Of Combination Regimens Based On Histone Deacetylase Inhibitors

Dana Farber Cancer Institute
Validation of Novel Combinations and Novel Compounds
Investigator: Constantine Mitsiades
Amount: $200,000
Year awarded: 2010

Development Of Preclinical Humanizeed Mouse Model Of Multiple Myeloma

The Jackson Laboratory
Research Fellow Award
Investigator: Mohit Verma
Amount: $75,000
Year awarded: 2014

Development Of Therapeutic Inhibitors For Treatment Of Multiple Myeloma.

The Hospital for Sick Children
Senior Research Award
Investigator: Chaim Roifman
Amount: $200,000
Year awarded: 2010

Effects Of IMiDs On Granulocytic Maturation

University of Pittsburgh
Senior Research Award
Investigator: Suzanne Lentzsch
Amount: $200,000
Year awarded: 2009

Effects Of JS-K, A GST Based NO Generator, On MM: Therapeutic Implications

Dana Farber Cancer Institute
Research Fellow Award
Investigator: Tanyel Kiziltepe Bilgicer
Amount: $75,000
Year awarded: 2006

Elucidation Of Therapeutic Targets In MMSET-associated Myeloma

Northwestern University Chicago
Target Credentialing Award
Investigator: Jonathan Licht
Amount: $250,000
Year awarded: 2010

Engineering T Cell Therapy For Multiple Myeloma

Fred Hutchinson Cancer Research Center
Senior Research Award
Investigator: Edus Warren
Amount: $200,000
Year awarded: 2011

Epigenetic Deregulation By The Multiple Myeloma SET Domain Protein

Northwestern University Chicago
Research Fellow Award
Investigator: Eva Martinez
Amount: $75,000
Year awarded: 2008

Epigenetic Deregulation By Loss Of The Histone Demehtylase UTX In MM

Northwestern University Chicago
Research Fellow Award
Investigator: Teresa Ezponda-Itoiz
Amount: $100,000
Year awarded: 2014

Erastin Analogs As Anti-myeloma Agents

Dana Farber Cancer Institute
Senior Research Award
Investigator: Constantine Mitsiades
Amount: $200,000
Year awarded: 2008

Erythropoietin As An Anti-Multiple Myeloma Immunomodulating Agent

Tel Aviv University
Senior Research Award
Investigator: Drorit Neumann
Amount: $200,000
Year awarded: 2010

Establishment Of A Panel Of Diverse Human Myeloma Cell Lines

Mayo Clinic Rochester
Cell Line Development Award
Investigator: Diane Jelinek
Amount: $100,000
Year awarded: 2006

Evaluating The In Vitro And In Vivo Effects Of Targeting IL-17 In Myeloma

Boston VA Research Institute
Senior Research Award
Investigator: Rao Prabhala
Amount: $200,000
Year awarded: 2009

Evaluation Of Novel STAT3 Inhibitors In Multiple Myeloma

Dana Farber Cancer Institute
Senior Research Award
Investigator: Erik Nelson
Amount: $200,000
Year awarded: 2007

Evaluation Of P97 As A Potential Target In Multiple Myeloma

California Institute of Technology
Research Fellow Award
Investigator: Tsui-Fen Chou
Amount: $75,000
Year awarded: 2008

Exploring The Role Of UCH-L1 In The Pathogenesis Of Myeloma

Mayo Clinic Rochester
Senior Research Award
Investigator: Paul Galardy
Amount: $200,000
Year awarded: 2010

Forward Chemical Genetic Approach To Protein Catabolism In Multiple Myeloma

Dana Farber Cancer Institute
Research Fellow Award
Investigator: Sridevi Ponduru
Amount: $75,000
Year awarded: 2007

From Laboratory To Clinic; Dimethylaminoparthenolide (DMAPT) In Myeloma

Indiana University Indianapolis
Validation of Novel Combinations
Investigator: Attaya Suvannasankha
Amount: $100,000
Year awarded: 2007

GFI-1 Suppression Of Osteoblast Differentiation In Myeloma

University of Pittsburgh
Senior Research Award
Investigator: G. David Roodman
Amount: $200,000
Year awarded: 2009

Generation Of Cell Lines From Primary Multiple Myeloma And MGUS Tumors

National Cancer Institute
Cell Line Development Award
Investigator: Michael Kuehl
Amount: $73,600
Year awarded: 2006

Genetic Screen To Identify Wnt Target Genes To Treat Myeloma

Dana Farber Cancer Institute
Senior Research Award
Investigator: Ruben Carrasco
Amount: $200,000
Year awarded: 2007

Genomic Changes In Plasma Cell Transformation To Myeloma In Vivo

German Cancer Research Center
Senior Research Award
Investigator: Kari Hemminki
Amount: $200,000
Year awarded: 2014

Genomic And Functional Characterization Of P53 Pathway In MM

Mayo Clinic Scottsdale
Research Fellow Award
Investigator: Wee Chng
Amount: $75,000
Year awarded: 2006

Glycosphingolipid Inhibitors In The Treatment Of Multiple Myeloma

Imperial College of Science
Validation of Novel Combinations and Novel Compounds
Investigator: Anastasios Karadimitris
Amount: $196,433
Year awarded: 2010

HDAC Inhibitors And BH3 Mimetics In Resistant/refractory Multiple Myeloma

Virginia Commonwealth University
Senior Research Award
Investigator: Steven Grant
Amount: $200,000
Year awarded: 2010

Harnessing Anti-SOX2 T Cells In Myeloma: Preclinical Studies

Yale University
Senior Research Award
Investigator: Madhav Dhodapkar
Amount: $200,000
Year awarded: 2009

Heparanase As A Target For Myeloma Treatment

Hadassah Medical Organization
Research Fellow Award
Investigator: Eyal Zcharia
Amount: $75,000
Year awarded: 2008

Heparanase As A Therapeutic Target For Regulation Of Myeloma Bone Disease

The University of Alabama at Birmingham
Senior Research Award
Investigator: Yang Yang
Amount: $200,000
Year awarded: 2011

Heparanase Inhibitor As Anti-metastatic Therapy For Myeloma

University of Alabama at Birmingham
Research Fellow Award
Investigator: Vishnu Prakash Ramani
Amount: $75,000
Year awarded: 2009

High Throughput Exon-scanning Of Kinome In Multiple Myeloma

Mayo Clinic Scottsdale
Senior Research Award
Investigator: Keith Stewart
Amount: $100,000
Year awarded: 2006

How Do BLMP1/PRDM1 And XBP1 Act As Tumor Suppressors In Multiple Myeloma

The Walter and Eliza Hall Institute of Medical Research
Senior Research Award
Investigator: Stephen Nutt
Amount: $200,000
Year awarded: 2014

Identification Of Novel Targets For T-Cell Immunotherapy Of Myeloma

Fred Hutchinson Cancer Research Center
Research Fellow Award
Investigator: Larry Anderson
Amount: $75,000
Year awarded: 2006

Identification Of Therapeutic Targets In The Non-Canonical NF-kB Pathway

Mayo Clinic Scottsdale
Research Fellow Award
Investigator: Jonathan Keats
Amount: $75,000
Year awarded: 2007

Identification Of Molecular Targets In Myeloma Microenvironments

University of Arkansas
Tumor Microenvironment Award
Investigator: Ya-Wei Qiang
Amount: $249,987
Year awarded: 2010

Identifying DKK1 As A Novel And Widely Expressed Tumor Antigen In MM

University of Texas
Research Fellow Award
Investigator: Jianfei Qian
Amount: $75,000
Year awarded: 2006

Identifying Ubiquitin Ligase Subtstrates Important For Myeloma Progression

University of California San Francisco
Senior Research Award
Investigator: David Toczyski
Amount: $200,000
Year awarded: 2014

Identifying Therapeutic Targets For FGFR3-associated MM

The Regents of the University of California
Senior Research Award
Investigator: Leslie Thompson
Amount: $200,000
Year awarded: 2006

Immunotherapy After ASCT For MM Using MAGE-A3/Poly-ICLC-primed T-cells

The University of Maryland
Senior Research Award
Investigator: Aaron Rapoport
Amount: $200,000
Year awarded: 2013

Impact Of HDAC6 Inhibition By ACY1215 And Bortezomib On MM Bone Disease

Massachusetts General Hospital
Research Fellow Award
Investigator: Eda Homare
Amount: $75,000
Year awarded: 2011

Improved Therapeutics: Targeting Sdc1/Integrin Pathways With SSTN

University of Wisconsin Madison
Research Fellow Award
Investigator: Valerie Trapp
Amount: $75,000
Year awarded: 2011

In-vivo Validation Of Novel Anti Myeloma Therapies

Mayo Clinic Scottsdale
Senior Research Award
Investigator: Marta Chesi
Amount: $200,000
Year awarded: 2009

Induction Of Myeloma Cell Susceptibility To NK Cells

Dana Farber Cancer Institute
Senior Research Award
Investigator: Roberto Bellucci
Amount: $200,000
Year awarded: 2010

Inhibition Of The Autophagic Survival Response To Enhance Chemotherapy

University of Arizona
Validation of Novel Combinations and Novel Compounds
Investigator: Terry Landowski
Amount: $200,000
Year awarded: 2008

Integrin Regulation Of Multiple Myeloma Trafficking

Dana Farber Cancer Institute
Senior Research Award
Investigator: Irene Ghobrial
Amount: $200,000
Year awarded: 2009

Investigating CDH2 Function In Myeloma Plasma Cells And Myeloma Stem Cells

University of Arkansas
Research Fellow Award
Investigator: James Stewart
Amount: $75,000
Year awarded: 2007

Investigating The Anti-Myeloma Effects Of Clioquinol

University Health Network
Research Fellow Award
Investigator: Mahadeo Sukhai
Amount: $75,000
Year awarded: 2009

Investigation Of TP53-regulated MicroRNAs And MRNAs In Multiple Myeloma

University of Arkansas
Research Fellow Award
Investigator: Wei Xiong
Amount: $75,000
Year awarded: 2008

Is N-cadherin Expression A Prognostic Indicator In Multiple Myeloma?

Institue of Medical and Veterinary Science
Research Fellow Award
Investigator: Kate Vandyke
Amount: $75,000
Year awarded: 2011

KIR-Ligand Mismatched Natural Killer Cell Therapy For Myeloma

University of Arkansas
Senior Research Award
Investigator: Frits van Rhee
Amount: $189,862
Year awarded: 2006

Macrophages Protect Myeloma Cells From Chemotherapy Drug-induced Apoptosis

University of Texas
Research Fellow Award
Investigator: Yuhuan Zheng
Amount: $75,000
Year awarded: 2010

Measuring The Apoptotic Preset As A Predictor Of Chemosensitivity

Dana Farber Cancer Institute
Research Fellow Award
Investigator: Triona Ni Chonghaile
Amount: $75,000
Year awarded: 2010

Mechanism And Efficacy Of Cyproheptadine As A Novel Anti-myeloma Agent

University Health Network
Senior Research Award
Investigator: Aaron Schimmer
Amount: $200,000
Year awarded: 2007

Mechanism Of Anti-tumor Effects Induced By Allogeneic Donor-cell Rejection

Massachusetts General Hospital
Research Fellow Award
Investigator: Toshiki Saito
Amount: $75,000
Year awarded: 2007

Mechanisms Of Lenalidomide Resistance

University of Texas
Senior Research Award
Investigator: Robert Orlowski
Amount: $200,000
Year awarded: 2010

Mechanisms Of Transformation In T(4;14) + Myeloma

Washington University in St. Louis
Senior Research Award
Investigator: Michael Tomasson
Amount: $200,000
Year awarded: 2011

Minimal Residual Disease To Better Characterize Multiple Myeloma Response And Detect Early Relapse

Ospedale-Molinette
Diagnostic Investment Award
Investigator: Antonio Palumbo
Amount: $500,000
Year awarded: 2010

Molecular Mechanisms Of Intrinsic Resistance Of Myeloma Cells To Bortezomib

Dartmouth College
Senior Research Award
Investigator: Alexei Kisselev
Amount: $200,000
Year awarded: 2010

Multi-Targeted Kinase Inhibition-Based Combination Strategies In Myeloma

Dana Farber Cancer Institute
Validation of Novel Combinations
Investigator: Constantine Mitsiades
Amount: $100,000
Year awarded: 2006

Multiple Myeloma Therapeutics Based On The Natural HDACi Largazole

Colorado State University
Senior Research Award
Investigator: Robert Williams
Amount: $200,000
Year awarded: 2009

Multiple Myeloma And Bone: Understanding The Destruction

Mayo Clinic Rochester
Research Fellow Award
Investigator: Matthew Drake
Amount: $75,000
Year awarded: 2007

Multiple Myeloma And Bone: Understanding The Destruction

Mayo Clinic Rochester
Research Fellow Award
Investigator: Matthew Drake
Amount: $75,000
Year awarded: 2007

Non-Genotoxic Activators Of P53 As Therapy For Multiple Myeloma

Mayo Clinic Rochester
Validation of Novel Combinations
Investigator: Shaji Kumar
Amount: $87,825
Year awarded: 2006

Novel Combination Therapies For Mutiple Myeloma

University of Alabama at Birmingham
Senior Research Award
Investigator: Yang Yang
Amount: $200,000
Year awarded: 2007

Novel Natural Products With Potential Therapeutic Uses In Multiple Myeloma

Mayo Clinic Rochester
Research Fellow Award
Investigator: Jennifer Tibodeau
Amount: $75,000
Year awarded: 2006

Novel Polymeric Targeting Nanocarrier For The Treatment Of Multiple Myeloma

The Regents of the University of California
Research Fellow Award
Investigator: Juntao Luo
Amount: $75,000
Year awarded: 2007

Novel Stromal Factors Driving Bortezomib-resistant NF-kappaB Activity In MM

University of Wisconsin Madison
Senior Research Award
Investigator: Shigeki Miyamoto
Amount: $200,000
Year awarded: 2011

Novel Treatment Approaches To Target The RARa2 Positive Myeloma Cell

University of Utah
Senior Research Award
Investigator: Fenghuang Zhan
Amount: $200,000
Year awarded: 2010

Novel Regulatory Properties Of Proteasomes In Multiple Myeloma

Harvard Medical School
Research Fellow Award
Investigator: Nikolay Kukushkin
Amount: $75,000
Year awarded: 2013

Obesity-associated Multiple Myeloma: Targeting The AMPK Pathway

University of Texas Health Science Center at San Antonio
Research Fellow Award
Investigator: Edward Medina
Amount: $75,000
Year awarded: 2012

On The Role Of CJun And CAbl In Multiple Myeloma

Dana Farber Cancer Institute
Senior Research Award
Investigator: Klaus Podar
Amount: $200,000
Year awarded: 2006

Osteoblast And Their Mesenchymal Progenitors In Myeloma.

University of Arkansas
Research Fellow Award
Investigator: Igor Entin
Amount: $75,000
Year awarded: 2007

Overcoming Lenalidomide Resistance In Multiple Myeloma

The University of Texas Md Anderson Cancer Center
Research Fellow Award
Investigator: Chad Bjorkland
Amount: $75,000
Year awarded: 2011

Overcoming Drug Resistance In MM: Development Of An In Vivo Mouse Model

University of Wuerzburg
Senior Research Award
Investigator: Ralf Bargou
Amount: $200,000
Year awarded: 2008

PARP Inhibitor As Novel Therapeutic Approach In Multiple Myeloma

University of Calgary
Research Fellow Award
Investigator: Ernesta Paola Neri
Amount: $75,000
Year awarded: 2010

Pathogen Discovery And Host-Viral Relationships In Multiple Myeloma

Dana Farber Cancer Institute
Research Fellow Award
Investigator: Akinyemi Ojesina
Amount: $75,000
Year awarded: 2011

Phosphoproteomic Analysis Of NF-kappaB In MM

Michigan State University
Senior Research Award
Investigator: Jetze Tepe
Amount: $200,000
Year awarded: 2008

Pre-clinical Study Of Daratumumab In Auto-SCT For MM And AL Amyloidosis

Tufts Medical Center
Research Fellow Award
Investigator: Chakra Chaulagain
Amount: $75,000
Year awarded: 2013

Pre-clinical Validation Of IL-6 For Translational Myeloma Research

University of Iowa
Senior Research Award
Investigator: Siegfried Janz
Amount: $200,000
Year awarded: 2009

Preclinical Investigation Of ABT-737 In Treatment Of Multiple Myeloma

University Health Network
Validation of Novel Combinations
Investigator: Xiao-Yan Wen
Amount: $100,000
Year awarded: 2006

Proteomic Profiling In Multiple Myeloma

University of Arkansas
Proteomics Award
Investigator: Ricky Edmonson
Amount: $750,000
Year awarded: 2007

Quantification Of Circulating Tumor Specific DNA In Multiple Myeloma

Johns Hopkins University
Diagnostic Investment Award
Investigator: William Matsui
Amount: $500,000
Year awarded: 2010

RAP-011, A Novel Activin Antagonist In The Treatment Of Myeloma

Massachusetts General Hospital
Validation of Novel Combinations and Novel Compounds
Investigator: Noopur Raje
Amount: $200,000
Year awarded: 2008

Radioimmunotherapy For Multiple Myeloma

Fred Hutchinson Cancer Research Center
Research Fellow Award
Investigator: Damian Green
Amount: $75,000
Year awarded: 2009

Refinement Of The XBP-1 Mouse Model Of Multiple Myeloma

Dana Farber Cancer Institute
Animal Model Development Award
Investigator: Yaoqi Wang
Amount: $200,000
Year awarded: 2007

Refining Mechanisms Of Resistance To Velcade: Clinical Implication

Dana Farber Cancer Institute
Senior Research Award
Investigator: Teru Hideshima
Amount: $100,000
Year awarded: 2006

Regulation Of Multiple Myeloma By Myeloid Cells

Moffitt Cancer Center and Research Institute
Tumor Microenvironment Award
Investigator: Yulia Nefedova
Amount: $250,000
Year awarded: 2010

Reversing Malignant Reprogramming Of Multiple Myeloma Cancer Stem Cells

University of California San Diego
Research Fellow Award
Investigator: Leslie Robertson
Amount: $75,000
Year awarded: 2013

Role Of Osteoclasts In The Regulation Of T-cell Immunity In Myeloma

University of Texas
Research Fellow Award
Investigator: Haiyan Li
Amount: $75,000
Year awarded: 2009

Role Of SLRPs In The Anti-myeloma Response Of Osteoblasts

University of Arkansas
Senior Research Award
Investigator: Shmuel Yaccoby
Amount: $99,759
Year awarded: 2006

Role Of Calcium In Mediating C-HYD1 And HYD1 Induced Cell Death In MM

Moffitt Cancer Center and Research Institute
Validation of Novel Combinations and Novel Compounds
Investigator: Lori Hazlehurst
Amount: $200,000
Year awarded: 2010

Role Of Osteoclasts In Immunosuppression In Myeloma

Cleveland Clinic Foundation
Senior Research Award
Investigator: Qing Yi
Amount: $200,000
Year awarded: 2014

Screening For Small Molecule Inhibitors Of MM Within Its Microenvironment

Massachusetts General Hospital
Research Fellow Award
Investigator: Shrikanta Chattopadhyay
Amount: $75,000
Year awarded: 2009

Small Molecule Inhibitors Of STAT3 In Multiple Myeloma

Princess Margaret Hospital
Research Fellow Award
Investigator: Victor Jimenez-Zepeda
Amount: $75,000
Year awarded: 2011

Stem Cell Rejection To Induce Anti-tumor Immunity

Massachusetts General Hospital
Senior Research Award
Investigator: Megan Sykes
Amount: $200,000
Year awarded: 2007

Studying The Myeloma Niche By 3D Mesenchymal Stem Cell-based System

Dana Farber Cancer Institute
Research Fellow Award
Investigator: Jana Jakubikova
Amount: $75,000
Year awarded: 2012

Synergistic Combinations Of Targeted Agents For Myeloma

Emory University
Validation of Novel Combinations
Investigator: Sagar Lonial
Amount: $100,000
Year awarded: 2006

Synergistic Effects Of PS-341 (Velcade) And BX471 On Multiple Myeloma

University of Pittsburgh
Validation of Novel Combinations
Investigator: Suzanne Lentzsch
Amount: $100,000
Year awarded: 2006

Synergy Of Aplidin And LBH589 With Conventional Anti-myeloma Treatments

Centro de Investigacion del Cancer
Validation of Novel Combinations
Investigator: Atanasio Pandiella
Amount: $100,000
Year awarded: 2006

TH17 Cytokines In Myeloma: Immunotherapeutic Targets

Boston VA Research Institute
Research Fellow Award
Investigator: Rao Prabhala
Amount: $75,000
Year awarded: 2008

TJP1: A Novel Modulator Of Proteasome Inhibitor Sensitivity And Resistance

University of Texas
Research Fellow Award
Investigator: Xingding Zhang
Amount: $75,000
Year awarded: 2013

Targeted Inhibition Of JAK-STAT Signalling To Modify MM Drug Resistance

Monash University
Validation of Novel Combinations and Novel Compounds
Investigator: Andrew Spencer
Amount: $197,308
Year awarded: 2010

Targeted Neutralization Of Regulatory T-cells To Improve Cancer Therapy

University Medical Center Utrecht
Senior Research Award
Investigator: Tuna Mutis
Amount: $200,000
Year awarded: 2011

Targeting Autophagy In Multiple Myeloma

Dana Farber Cancer Institute
Senior Research Award
Investigator: James Bradner
Amount: $200,000
Year awarded: 2010

Targeting CD40 Therapy Using Humanized Mabs Alone Or With ImiD3 In Human Multiple Myeloma

Dana Farber Cancer Institute
Senior Research Award
Investigator: Yu-Tzu Tai
Amount: $100,000
Year awarded: 2006

Targeting DEPTOR In Multiple Myeloma

Brentwood Biomedical Research Institute
Research Fellow Award
Investigator: Yonghui Yang
Amount: $75,000
Year awarded: 2011

Targeting Deubiquitylase Enzyme USP-7 As Therapy In Myeloma

Dana Farber Cancer Institute
Validation of Novel Combinations and Novel Compounds
Investigator: Dharminder Chauhan
Amount: $200,000
Year awarded: 2008

Targeting Met Receptor Tyrosine Kinase In Multiple Myeloma

University of Texas
Senior Research Award
Investigator: Christine Stellhecht
Amount: $200,000
Year awarded: 2011

Targeting UBC13 For Multiple Myeloma Treatment

Burnham Institute for Medical Research
Research Fellow Award
Investigator: Charitha Madiraju
Amount: $75,000
Year awarded: 2010

Targeting Vascular Endothelial Growth Factor For Treatment Of Myeloma

Mayo Clinic Rochester
Senior Research Award
Investigator: Shaji Kumar
Amount: $200,000
Year awarded: 2007

Targeting Wnt Signaling In Myeloma Using Stabilized Alpha-Helices Of BCL9

Dana Farber Cancer Institute
Senior Research Award
Investigator: Ruben Carrasco
Amount: $200,000
Year awarded: 2008

Targeting Wnt Signaling Network To Enhance Chemotherapy In MM

Moffitt Cancer Center and Research Institute
Senior Research Award
Investigator: Yulia Nefedova
Amount: $200,000
Year awarded: 2009

Targeting A Third NF-KB Pathway For Anti-myeloma Drug Development.

University of Wisconsin Madison
Senior Research Award
Investigator: Shigeki Miyamoto
Amount: $200,000
Year awarded: 2008

Targeting P90RSK By A Highly Specific Inhibitor Fmk In Multiple Myeloma

Emory University
Validation of Novel Combinations
Investigator: Jing Chen
Amount: $100,000
Year awarded: 2006

Targeting Protein-protein Interactions In Myeloma TORC Complexes

Brentwood Biomedical Research Institute
Senior Research Award
Investigator: Alan Lichtenstein
Amount: $200,000
Year awarded: 2011

Targeting The MUC1 Oncoprotein In Multiple Myeloma

Dana Farber Cancer Institute
Validation of Novel Combinations and Novel Compounds
Investigator: Donald Kufe
Amount: $200,000
Year awarded: 2008

Targeting The SCF/skp2 Pathway For The Treatment Of Multiple Myeloma

University of North Carolina at Chapel Hill
Research Fellow Award
Investigator: Qing Chen
Amount: $75,000
Year awarded: 2006

Targeting The Unfolded Protein Response For Cancer Therapy

Stanford University
Senior Research Award
Investigator: Albert Koong
Amount: $200,000
Year awarded: 2010

Targeting Type 1 IFN And TRAIL To MM Using Anti-CD138 Fusion Proteins

The Regents of the University of California
Senior Research Award
Investigator: Sherie Morrison
Amount: $200,000
Year awarded: 2010

The NFKB2-IL10 Pathway In Multiple Myeloma Pathogenesis

Medical College of Georgia Research Institute
Research Fellow Award
Investigator: Brian McCarthy
Amount: $75,000
Year awarded: 2010

The Role Of EMMPRIN In Myeloma Cell Biology And Disease Progression

Mayo Clinic
Senior Research Award
Investigator: Diane Jelinek
Amount: $200,000
Year awarded: 2011

The Role Of MDSCs In The Immune Escape Of Multiple Myeloma

Moffitt Cancer Center and Research Institute
Research Fellow Award
Investigator: Indu Ramachandran
Amount: $75,000
Year awarded: 2012

The Role Of MMSET In Regulation Of Chromatin Structure In T(4;14)+ Myeloma

Northwestern University Chicago
Research Fellow Award
Investigator: Relja Popovic
Amount: $75,000
Year awarded: 2011

The Role Of NFkB Pathway Mutations In Multiple Myeloma

Mayo Clinic Scottsdale
Senior Research Award
Investigator: Leif Bergsagel
Amount: $200,000
Year awarded: 2007

The Role Of Selectins In Multiple Myeloma

Dana Farber Cancer Institute
Research Fellow Award
Investigator: Abdel Kareem Azab
Amount: $75,000
Year awarded: 2008

The Role Of C-FLIP In Multiple Myeloma

Indiana University Indianapolis
Research Fellow Award
Investigator: Attaya Suvannasankha
Amount: $75,000
Year awarded: 2007

The Activity Of Novel PI3K Inhibitors In Myeloma

Institute of Cancer Queen Mary University of London
Validation of Novel Combinations and Novel Compounds
Investigator: Simon Joel
Amount: $199,984
Year awarded: 2008

The Function Of Irf4 And Blimp1 In Normal And Malignant Plasma Cells

The Walter and Eliza Hall Institute of Medical Research
Senior Research Award
Investigator: Stephen Nutt
Amount: $200,000
Year awarded: 2011

The Humanized Multiple Myeloma Mouse Model

University Medical Center Utrecht
Senior Research Award
Investigator: Anton Martens
Amount: $200,000
Year awarded: 2010

Therapeutic Targeting Of Ire1/XBP-1 In Malignant B Cells

Stanford University
Research Fellow Award
Investigator: Douglas Feldman
Amount: $75,600
Year awarded: 2006

Therapeutic Targeting Of Notch And Bcl-2/bcl-xL In Multiple Myeloma

Moffitt Cancer Center and Research Institute
Senior Research Award
Investigator: Yulia Nefedova
Amount: $200,000
Year awarded: 2007

The Role Of SCF Ubiquitin Ligases In Multiple Myeloma

New York University School of Medicine
Senior Research Award
Investigator: Michele Pagano
Amount: $200,000
Year awarded: 2007

The Role Of XBP1s In Multiple Myeloma Microenvironment

University of Pittsburgh
Tumor Microenvironment Award
Investigator: Hongjiao Ouyang
Amount: $249,950
Year awarded: 2010

The Role Of Hypoxia In The Micro-residual Disease In Multiple Myeloma

Washington University in St. Louis
Research Fellow Award
Investigator: Barbara Muz
Amount: $75,000
Year awarded: 2013

The Role Of Survival Proteins In Multiple Myeloma Development

The Walter and Eliza Hall Institute of Medical Research
Research Fellow Award
Investigator: Victor Peperzak
Amount: $75,000
Year awarded: 2010

Tissue-Based Array Classification Of Multiple Myeloma

University of Calgary
Research Fellow Award
Investigator: Alex Klimowicz
Amount: $75,000
Year awarded: 2008

Towards MM Immunotherapy By Adoptive Transfer Of Idiotype-specific T Cells

University of Oslo
Senior Research Award
Investigator: Bjarne Bogen
Amount: $200,000
Year awarded: 2007

Towards Small Molecule GRK6 Inhibitors As Therapuetics For Multiple Myeloma

University Health Network
Research Fellow Award
Investigator: Kim Chan Chung
Amount: $75,000
Year awarded: 2014

Transgenic Mouse Model Of Drug Development For Multiple Myeloma

Mayo Clinic Scottsdale
Research Fellow Award
Investigator: Michael Sebag
Amount: $75,000
Year awarded: 2006

Transient Lymphodepletion And PD-1/PD-L1 Blockade To Treat Myeloma

Medical College of Wisconsin
Senior Research Award
Investigator: Bryon Johnson
Amount: $200,000
Year awarded: 2012

Translation Studies Of IGFS/IGF-1R

Dana Farber Cancer Institute
Senior Research Award
Investigator: Constantine Mitsiades
Amount: $100,000
Year awarded: 2006

Treating Multiple Myeloma Using Anti-CD138 Genetically Fused To Type 1 IFN

The Regents of the University of California
Senior Research Award
Investigator: Sherie Morrison
Amount: $200,000
Year awarded: 2013

Treatment Of Multiple Myeloma With A Humanized Mononclonal Antibody

Temple University
Senior Research Award
Investigator: Robert Colman
Amount: $100,000
Year awarded: 2006

Tryptophan Metabolism In The Immune Dysregulation Of Multiple Myeloma

University of Turin
Research Fellow Award
Investigator: Francesca Fiore
Amount: $75,000
Year awarded: 2007

Type I MAGE MRNA-pulsed Dendritic Cell Vaccines For Multiple Myeloma

New York University School of Medicine
Validation of Novel Combinations
Investigator: Hearn Cho
Amount: $100,000
Year awarded: 2006

UTX Regulates Spontaneous And Bortezomib-induced Apoptosis In Myeloma

Mayo Clinic Scottsdale
Research Fellow Award
Investigator: Ryan Holzer
Amount: $75,000
Year awarded: 2012

Understanding The Myeloid Microenvironment In Multiple Myeloma

Health Research Incorporated
Tumor Microenvironment Award
Investigator: Kelvin Lee
Amount: $250,000
Year awarded: 2010

Understanding The Resistant Plasma Cell: The Dream Of Curing Myeloma

Fundacion de Investigacion de Cancer
Research Fellow Award
Investigator: Bruno Paiva
Amount: $75,000
Year awarded: 2012

Vaccination And T Cell Therapy Using DC/Myeloma Fusions With Transplant

Beth Israel Deaconess Medical Center
Senior Research Award
Investigator: David Avigan
Amount: $200,000
Year awarded: 2008

Validating MiR-30 As A Novel Therapeutic Tool For Multiple Myeloma

Dana Farber Cancer Institute
Research Fellow Award
Investigator: Jianjun Zhao
Amount: $75,000
Year awarded: 2011

Validation Of Potential Driver Mutations In Multiple Myeloma Cohort

Mayo Clinic Scottsdale
Research Fellow Award
Investigator: Jan Egan
Amount: $75,000
Year awarded: 2011

Validation Of An Anti-JAG2 MAb For Treatment Of Multiple Myeloma

Health Research Incorporated
Senior Research Award
Investigator: Lionel Coignet
Amount: $200,000
Year awarded: 2007

Validation Of Pyrimidinetriones As Potential Therapy For Multiple Myeloma

Cornell University
Validation of Novel Combinations and Novel Compounds
Investigator: Hsiou-Chi Liou
Amount: $200,000
Year awarded: 2008

Validation Of Withaferin A As An Anti-myeloma Compound

Universiteit Gent
Validation of Novel Combinations and Novel Compounds
Investigator: Wim Vanden Berghe
Amount: $199,088
Year awarded: 2008

WNT Receptors: Targets To Disrupt MM Interaction With The Microenvironment

Fondazione Centro San Raffaele del Monte Tabor
Research Fellow Award
Investigator: Michela Frenquilli
Amount: $75,000
Year awarded: 2011

Whole Transcriptome RNA Sequencing Of Multiple Myeloma Tumors Using Next Generation Sequencing Technologies

Translational Genomics Research Institute
Genomics Award
Investigator: John Carpten
Amount: $672,000
Year awarded: 2010

Anti-KIR And Lenalidomide Enhances The NK Cell Vs Multiple Myeloma Effect

Ohio State University Research Foundation
Research Fellow Award
Investigator: Don Benson
Amount: $75,000
Year awarded: 2009

P62 Signaling As A Therapeutic Target For Multiple Myeloma

University of Pittsburgh
Senior Research Award
Investigator: Noriyoshi Kurihara
Amount: $200,000
Year awarded: 2009

Johns Hopkins University School of Medicine
Collaborative Program Grant
Amount: $1,500,000.00
Year awarded: 2002

A Gene Therapy Approach For Multiple Myeloma

Mayo Clinic
Fellows' Award
Investigator: David Dingli, MD
Year awarded: 2001

AKT-mediated Regulation Of Sensitization Of Multiple Myeloma Cells To MTOR Inhibitors

West LA VA Medical Center
Fellows' Award
Investigator: Patrick Frost, PhD
Year awarded: 2005

AKT/p70S6K/4E-BPI Cascade In Multiple Myeloma

VA West LA Hospital- UCLA Medical School
Senior Research Award
Investigator: Alan Lichtenstein, MD
Year awarded: 2000

A Model For The In Vivo Growth Of Multiple Myeloma In The Bone Marrow Microenvironment

Dana Farber Cancer Institute
Fellows' Award
Investigator: Richard LeBlanc, MD
Year awarded: 2001

A Novel Multiplex Drug Screening Assay (MDSA) Of Compounds Related To Multiple Myeloma

University of Pittsburgh Cancer Center
RFA: Compound Library Screening
Investigator: Suzanne Lentzsch, MD, PhD
Year awarded: 2005

Adhesion-mediated Effects On MTOR In MM Cells

UCLA West LA VA Medical Center
Fellows' Award
Investigator: Bao Hoang, PhD
Year awarded: 2004

Adoptive T-Cell Therapy In Multiple Myeloma

University Hospital, The Netherlands
Senior Research Award
Investigator: Henk Lokhorst, MD, PhD
Year awarded: 1998

Analysis Of CYP1B1 Specific T Cells In Multiple Myeloma Patients

Dana Farber Cancer Institute
Fellows' Award
Investigator: Britta Maecker, MD
Year awarded: 2000

Angiogenic Growth Factors As A Therapeutic Target In Myeloma

University of Arizona
Senior Research Award
Investigator: William T. Bellamy, PhD
Year awarded: 1999

Anti-Apoptosis Mechanisms Of Mcl-1 In Multiple Myeloma

University of Maryland, Baltimore
Fall Senior Research Award
Investigator: Robert G. Fenton, MD, PhD
Year awarded: 2002

Antigen Induced Myeloma

Mayo Clinic Arizona
Fellows' Award
Investigator: Maurizio Affer, PhD
Year awarded: 2005

Apoptosis Of Multiple Myeloma Cells Induced By FasL And TRAIL/Apo2L: Therapeutic Applications

Dana-Farber Cancer Institute
Senior Research Award
Investigator: Nicholas Mitsiades, MD, PhD
Year awarded: 2001

Apoptotic And Survival Proteins As Novel Therapeutic Targets In Multiple Myeloma

Dana Farber Cancer Institute
Senior Research Award
Investigator: Dharminder Chauhan, PhD
Year awarded: 2000

Arsenic Trioxide And Ascorbic Acid As Treatment For Multiple Myeloma

University of Miami School of Medicine
Senior Research Award
Investigator: Lawrence H. Boise, PhD
Year awarded: 2001

Augmentation Of Anti-myeloma Activity Of Conventional/Novel Agents By Inhibition Of Akt Using A Novel Alkyl-phospholipid, Perifosine

Dana Farber Cancer Institute
RFA: Translational Research
Investigator: Teru Hideshima, MD, PhD
Year awarded: 2005

B1 Integrin-Initated Signaling Events Regulate The Subcellular Localization Of C-FLIP L Following Adhesion To Fibronectin, Protecting Adhered MM Cells From CD95-Mediated Apoptosis

H. Lee Moffitt Cancer Center and Research Institute
Fellows' Award
Investigator: Kenneth Shain, PhD
Year awarded: 2001

Biologic Sequelae Of CD40 Signaling In Human Multiple Myeloma

Dana-Farber Cancer Institute
Senior Research Award
Investigator: Yu Tzu-Tai, PhD
Year awarded: 2002

Biologic Sequelae Of Interleuken-6 Induced PI3-K/Akt Signaling In Multiple Myeloma

Dana-Farber Cancer Institute
Senior Research Award
Investigator: Teru Hideshima, MD, PhD
Year awarded: 2001

Cataloguing The Expressed Gene Profile Of Multiple Myeloma

Princess Margaret Hospital, Canada
Senior Research Award
Investigator: Keith Stewart, MD
Year awarded: 2001

Cell Therapy Of Multiple Myeloma-Induction Of An Anti-MAGE Response

Vrije Universiteit Brussels
Senior Research Award
Investigator: Kris Thielemans, MD, PhD
Year awarded: 1998

Characterizing The Binding Interaction Between Tamm-Horsfall Protein And Immunoglobulin Light Chains

University of Alabama at Birmingham
Senior Research Award
Investigator: Paul W. Sanders, MD
Year awarded: 2001

Checkpoint Abrogation And MEK/MAPK Inhibition: A Novel Strategy For The Treatment Of Multiple Myeloma

Virginia Commonwealth University
Senior Research Award
Investigator: Steven Grant, MD
Year awarded: 2001

Conditional Knockout Of A Putative Tumor Suppressor Gene CHC1L In Multiple Myeloma

Toronto General Research Institute / Toronto General Hospital
Fellows' Award
Investigator: Chang-Xin Shi, PhD
Year awarded: 2005

Cytolytic T Lymphocyte (CTL) Mediated Immunotherapy Of Multiple Myeloma Using Gene Modified Dendritic Cells

University of Arkansas for Medical Sciences
Fellows' Award
Investigator: Ramesh B. Batchu, Ph.D.
Year awarded: 2002

Defining Mechanisms Of Resistance To Velcade: Clinical Implication

Dana-Farber Cancer Institute
Senior Research Award
Investigator: Teru Hideshima, M.D., Ph.D.
Year awarded: 2004

Defining The Role Of BAFF And APRIL In Multiple Myeloma And Its Bone Marrow Milieu: Therapeutic Implications

Dana-Farber Cancer Institute
Senior Research Award
Investigator: Noopur Raje, MD
Year awarded: 2005

Dendritic Cell Based Vaccination For Multiple Myeloma

Duke University Medical Center
Fellows' Award
Investigator: Cristina Gasparetto, MD
Year awarded: 2001

Dendritic Cell Strategies Combined With Chemotherapy Against Multiple Myeloma

North Shore LIJ Health System
Fellows' Award
Investigator: Youzhi Tong, PhD
Year awarded: 2000

Determination Of Antigen-Specific Immunity In Myeloma Patients

Dana-Farber Cancer Institute
Senior Research Award
Investigator: Joachim L. Schultze, MD
Year awarded: 2000

Development And Trial Of DNA Vaccines Against Multiple Myeloma

University of Southampton, UK
Senior Research Award
Investigator: F.K. Stevenson, DPhil and Francesco Forconi, MD
Year awarded: 2000

Development Of Molecularly-Based Combination Therapy For Multiple Myeloma

Dana-Farber Cancer Institute
Collaborative Program Grant
Investigator: Kenneth C. Anderson, MD
Amount: $1,500,000.00
Year awarded: 2004

Development Of Novel Target-based Therapies For Multiple Myeloma


Collaborative Program Grant
Year awarded: 2001

Development Of Artificial Antigen Presenting Cells For Adoptive Immunotherapy Of Multiple Myeloma

Johns Hopkins University School of Medicine
Senior Research Award
Investigator: Jonathan Schneck, MD, PhD
Year awarded: 2003

Development Of Novel Targeted Therapy For Multiple Myeloma

University of Utah - Huntsman Cancer Institute
Senior Research Award
Investigator: Ray Lee, MD, PhD
Year awarded: 2005

Dissecting The PI3K/PTEN/Akt/NF-kB Pathway In Myeloma Malignant Transformation

Georgetown University Medical School
Senior Research Award
Investigator: Weiqun Li, MD
Year awarded: 2002

Donor Lymphocyte Infusions Combined With Autologous Antigen Presenting Cells To Improve The Graft-versus-myeloma Effect

University Medical Center Utrecht
Senior Research Award
Investigator: Henk Lokhorst, MD, PhD
Year awarded: 2005

Effects Of Farnesyl Transferase Inhibitors (FTI) In Combination With Cytotoxic Chemotherapy Or Other Drugs Targeting Ras Processing On Myeloma Tumor Burden, In A SCID-hu Model Of Human Myeloma: A Preclinical Study

H. Lee Moffitt Cancer Center
Senior Research Award
Investigator: Melissa Alsina, MD
Year awarded: 2001

Effects Of HYD1 On Melphalan Sensitivity In A SCID-Hu In-vivo Multiple Myeloma Model

Moffitt Cancer Center
RFA: Translational Research
Investigator: Lori Hazlehurst, PhD
Year awarded: 2005

Endothelial Progenitor Cells And Multiple Myeloma: Prognosis And Treatment

SUNY Downstate Medical Center
Senior Research Award
Investigator: Olcay Batuman, MD
Year awarded: 2005

Epigenetic Profiling In Multiple Myeloma

The Curators of the University of Missouri-Columbia
Senior Research Award
Investigator: Huidong Shi, Ph.D.
Year awarded: 2004

Evaluation Of A Regulatory Site In The Ubiquiting-conjugating Enzyme Cdc34 As A Potential Therapeutic Target For The Treatment Of Multiple Myeloma

St. Vincent's Institute of Medical Research
Senior Research Award
Investigator: Borislav Sarcevic, BSc, PhD
Year awarded: 2005

Examining IL-8 And The Pathogenesis Of Multiple Myeloma

Mayo Clinic - Rochester
Fellows' Award
Investigator: Michael P. Kline, PhD
Year awarded: 2005

Functional Characterization Of The Multiple Myeloma SET Domain (MMSET) Protein

Mount Sinai Medical School-Mount Sinai Medical Center
Fellows' Award
Investigator: Leonardo Andres Sirulnik, MD, PhD
Year awarded: 2002

Functional Characterization Of The Multiple Myeloma Set Domain Protein

Mount Sinai School of Medicine
Fall Senior Research Award
Investigator: Jonathan D. Licht, MD
Year awarded: 2002

Functional Characterization Of MMSET In-vivo

Mayo Clinic College of Medicine
Senior Research Award
Investigator: Marta Chesi, PhD
Year awarded: 2005

Gene Expression Profile Of Vascular Endothelial Cells In Patients With Multiple Myeloma And Its Clinical Significance

SUNY-Downstate Medical Center
Senior Research Award
Investigator: Olcay Batuman, MD
Year awarded: 2001

Genetic Vaccination Against Multiple Myeloma.

Southampton University in the United Kingdom
Senior Research Award
Investigator: Freda Stevenson, DPhil
Year awarded: 1998

Glycogen Synthase Kinase 3 As A Potential Target For Therapy In Multiple Myeloma

University of Chicago
Senior Research Award
Investigator: Amittha Wickrema, PhD
Year awarded: 2002

Heat Shock Proteins As Targets For Immunotherapy In Multiple Myeloma

The University of Texas MD Anderson Cancer Center
Senior Research Award
Investigator: Qing Yi, MD, PhD
Year awarded: 2005

High Potency Immunodominant Peptide Immunotherapy

Royal Prince Alfred Hospital, Australia
Fellows' Award
Investigator: Daniel Man-Yuen Sze, PhD
Year awarded: 2002

High Throughout Exon-scanning Of The Kinome In Multiple Myeloma

Toronto General Research Institute, University Health Network
Senior Research Award
Investigator: Jaime O. Claudio, Ph.D.
Year awarded: 2004

Id-specific T Cells In Multiple Myeloma

University of Oslo
Senior Research Award
Investigator: Bjarne Bogen, MD, PhD
Year awarded: 1999

Identification And Characterization Of 14q32 Translocations In Patients With Monoclonal Gammopathy Of Undetermined Significance

Mayo Clinic, Rochester
Fellows' Award
Investigator: Rafael Fonseca, MD
Year awarded: 1998

Identification Of Gene Expression Patterns Associated With Prognosis And Outcome In Multiple Myeloma

Mayo Clinic
Senior Research Award
Investigator: Diane F. Jellinek, PhD
Year awarded: 2000

Identification Of Genetic Markers During Multistep Malignant Transformation Of Multiple Myeloma

Memorial Sloan Kettering Cancer Center
Fellows' Award
Investigator: Pulivarthi Rao, PhD
Year awarded: 1998

Identification Of Inhibitors Of Light Chain Amyloidosis

University of Tennessee Graduate School of Medicine
Senior Research Award
Investigator: Jonathan Stuart Wall, PhD
Year awarded: 2003

Identification Of Molecular Markers That Determine PS-341 Sensitivity (or Resistance) In Multiple Myeloma

Dana-Farber Cancer Institute
Fellows' Award
Investigator: Reshma Shringarpure, PhD
Year awarded: 2003

Identification Of Novel Therapeutic Targets In Multiple Myeloma

Princess Margaret Hospital, University Health Network
Senior Research Award
Investigator: A. Keith Stewart, MB.CHB, F.R.C.P.C., MBA
Year awarded: 2003

Identifying New Antigens For Targeted Therapy In Multiple Myeloma

Southampton University Hospitals
Senior Research Award
Investigator: Surinder S. Sahota, PhD
Year awarded: 2002

Idiotypic Immunization Of Multiple Myeloma Patients Using The Autologous M-protein In Combination With IL-12 Or IL-12 And GM-CSF

Karolinska Hospital, Sweden
Fellows' Award
Investigator: Anders Osterborg, MD
Year awarded: 1998

Immune Assessment After Autotransplantation Followed By Adoptive Transfer Of Ex Vivo Costimulated Autologous T-cells In Conjunction With Pneumococcal Conjugate Vaccine Immunization For Patients With Multiple Myeloma

University of Pennsylvania
Fellows' Award
Investigator: Nichole Aqui, MD
Year awarded: 2004

Immunobiology Of Lymphohematopoietic GVH Reactions

Massachusetts General Hospital
Senior Research Award
Investigator: Megan Sykes, MD
Year awarded: 2005

Immunobiology Of Lymphohematopoietic GVH Reactions

Massachusetts General Hospital
Senior Research Award
Investigator: Megan Sykes, M.D.
Year awarded: 2004

Immunostimulatory DNA: Application To DNA Based Vaccines For Multiple Myeloma

University of California, San Diego
Senior Research Award
Investigator: Helen Tighe, PhD
Year awarded: 1999

Immunotherapeutic Approach To Multiple Myeloma

Dana Farber Cancer Institute
Fellows' Award
Investigator: Toshiaki Hayashi, MD, PhD
Year awarded: 2001

Immunotherapy Of Multiple Myeloma: Reversal Of Tolerance And Improved Id-Vaccination

University of Oslo
Senior Research Award
Investigator: Bjarne Bogen, MD, PhD
Year awarded: 2002

Immunotherapy Targeting Multiple Myeloma Specific Antigens

University of Florida
Senior Research Award
Investigator: Lung-Ji Chang, Ph.D.
Year awarded: 2004

Immunotherapy With Myeloma-specific Cytotoxic T Lymphocytes

University of Arkansas for Medical Sciences
Fall Senior Research Award
Investigator: Frits van Rhee, MD, PhD
Year awarded: 2002

Inhibition Of IL-1 In The Myeloma Microenvironment

Mayo Clinic
Fall Senior Research Award
Investigator: John A. Lust, MD, PhD
Year awarded: 2002

Interleukin-6 (IL-6) Induced SHP2 Activation Mediates Resistance To Dexamethasone (Dex) &Mac246; Induced RAFTK Activation And Apoptosis In Multiple Myeloma Cells

Dana-Farber Cancer Institute
Fellows' Award
Investigator: Dharminder Chauhan, PhD
Year awarded: 1999

Involvement Of Fanconi Anemia/BRCA DNA Repair Pathway In Acquired Melphalan Drug-resistant Myeloma Cells

H. Lee Moffitt Cancer Center
Fellows' Award
Investigator: Qing Chen, PhD
Year awarded: 2004

Is The Transcription Factor XBP-1 A Critical Target For Proteasome Inhibitors In Multiple Myeloma?

Harvard School of Public Health
Senior Research Award
Investigator: Laurie H. Glimcher, MD
Year awarded: 2002

Mechanism/s Of Osteolytic Lesions In Multiple Myeloma: The Role Of The Osteoblasts

University of Bari, Italy
Fellows' Award
Investigator: Giacomina Brunetti, PhD
Year awarded: 2005

Mechanism Of Kidney Failure In Multiple Myeloma

University of Oklahoma Health Science Center
Fellows' Award
Investigator: Satish Kumar, MD
Year awarded: 2000

Mixed Chimera Transplants Followed By Idiotype Vaccinations For Multiple Myeloma

Stanford University
Senior Research Award
Investigator: Keith E. Stockert Goldstein, MD
Year awarded: 1999

Molecular Mechanism Of MTOR Inhibition As A Therapeutic Modality For Multiple Myeloma

University of Pittsburgh
Fellows' Award
Investigator: Yazan M. Alsayed, MD
Year awarded: 2005

Molecular Mechanisms And Synergy Between Proteasome Inhibition And Farnesyl Transferase Inhibition In Multiple Myeloma Cells

Winship Cancer Center, Emory University
Fellows' Award
Investigator: Ebenezer David, PhD
Year awarded: 2004

Mouse Myeloma Models With Targeted Chromosome 14 Deletions

Toronto General Research Institute, University Health Network, Canada
Senior Research Award
Investigator: Xiao-Yan Wen, MD, PhD
Year awarded: 2005

Myeloma-Microenvironment Interaction Dynamics: The Involvement Of Bone Cells

University of Arkansas for Medical Sciences
Senior Research Award
Investigator: Dr. Shmuel Yaccoby, PhD
Year awarded: 2001

Myeloma Vaccine Development

Toronto General Hospital
Senior Research Award
Investigator: A. Keith Stewart, MD
Year awarded: 1998

Notch Signaling As A New Molecular Target In Multiple Myeloma

H. Lee Moffitt Cancer Center
Senior Research Award
Investigator: Dmitry I. Gabrilovich, MD, PhD
Year awarded: 2005

Optimization Of Dendritic Cell-Based Immunotherapy In Multiple Myeloma

University of Arkansas for Medical Science
Senior Research Award
Investigator: Qing Yi, MD, PhD
Year awarded: 2000

Optimization Of Dendritic Cell Preparation And MRNA Loading For Multiple Myeloma Immunotherap

Mater Medical Research Institute
Fellows' Award
Investigator: Dr Cameron Turtle, MBBS, FRACP, FRCPA
Year awarded: 2001

Potent Enhancement Of Conventional Multiple Myeloma Chemotherapy By DMC, A Novel Drug With Multifaceted Molecular Actions

University of Southern California Keck Medical School
RFA: Translational Research
Year awarded: 2005

Preclinical Toxicology And Pharmacology Of MV-NIS, A Replicating Measles Virus For Myeloma Gene Therapy

Mayo Clinic
Fellows' Award
Investigator: David Dingli, MD
Year awarded: 2003

Prime-boost DNA/Adeno-associated Viral (AAV) Vaccine For Multiple Myeloma With MAGE A3-NY-ESO-1 Fusion Genes

University of Arkansas for Medical Science
Senior Research Award
Investigator: Ramesh B. Batchu, Ph.D.
Year awarded: 2004

Probing The Ubiquitin-Proteasome Pathway In Multiple Myeloma

Harvard Medical School
Senior Research Award
Investigator: Benedikt Kessler, PhD
Year awarded: 2002

Profiling IL-6 And Stromal Induced Gene Expression And Signal Transduction In Myeloma Cell Lines

University of Minnesota
Senior Research Award
Investigator: Brian Van Ness, PhD
Year awarded: 2000

Program Pathogenesis And Treatment Of Myeloma Bone Disease


Collaborative Program Grant
Amount: $1,500,000.00
Year awarded: 2003

Proteasome Inhibition And The Terminal Unfolded Protein Response

University of Miami Miller School of Medicine
Senior Research Award
Investigator: Lawrence H. Boise, PhD
Year awarded: 2005

Purified Blood DC Vaccination With Multiple Myeloma

Mater Medical Research Institute, Australia
Senior Research Award
Investigator: Derek Nigel John Hart, MB, ChB, DPhil
Year awarded: 2002

Pyk2 Phosphorylation By FGFR3 In Multiple Myeloma

University of California, San Diego
Senior Research Award
Investigator: Daniel J. Donoghue, PhD
Year awarded: 2002

Randomized Phase II Trial Of Dendritic Cell-Based Idiotype And Post-Transplant Multiple

Mayo Clinic
Fellows' Award
Investigator: Martha Lacy, MD
Year awarded: 2001

Recombinant Immunotoxins For Minor Histocompatibility Antigen Based Treatment Of Multiple Myeloma

Leiden University Medical Center
Senior Research Award
Investigator: Els Goulmy, PhD
Year awarded: 2005

Renoprotection In Multiple Myeloma By Pituitary Adenylate Cyclase Activating Polypeptide

Tulane University Health Sciences Center
Fellows' Award
Investigator: Min Li, MD, PhD
Year awarded: 2005

Role Of Bone Marrow Stromal Cells In De Novo Resistance Of Myeloma Cells To Chemotherapeutic Drugs

H. Lee Moffitt Cancer Center at the University of South Florida
Fellows' Award
Investigator: Yulia Nefedova, MD, PhD
Year awarded: 2002

Role Of GILZ In The Blucocorticoid Signaling Pathway Of Multiple Myeloma

Northwestern University
Senior Research Award
Investigator: Nancy Krett, PhD
Year awarded: 2003

Role Of MIP-1a In Myeloma Bone Disease

University of Texas Health Science Center of San Antonio
Senior Research Award
Investigator: G. David Roodman, MD, PhD
Year awarded: 2000

Role Of STAT3 In Multiple Myeloma

New York University School of Medicine
Fellows' Award
Investigator: Manual A. Macapinlac, Jr., MD
Year awarded: 2002

Role Of Differential CD8 T Cell Therapies For Mm

Harvard Medical School
Fellows' Award
Investigator: Irina B. Mazo, MD, PhD
Year awarded: 2004

Role Of The Non-hematopoietic Bone Marrow Stroma In Multiple Myeloma: In Vivo Studies With Primary Myeloma Cells In The SCID-hu Host

University of Arkansas for Medical Sciences
Fellows' Award
Investigator: Shmuel Yaccoby, PhD
Year awarded: 1999

Role Of The Alternative NF-_B Pathway In Multiple Myeloma

University of Pittsburgh
Senior Research Award
Investigator: Preet M. Chaudhary, MD, PhD
Year awarded: 2005

Screening A Chemical Library Tio Identify Novel Inhibitors Of C-maf-mediated Cyclin D2 Transactivation

Princess Margaret Hospital and Ontario Cancer Center
RFA: Compound Library Screening
Investigator: David Schimmer, MD, PhD
Year awarded: 2005

Screening For Inhibitors Of Transcription Factors Essential For The Survival Of Multiple Myeloma Cells: STAT3 And NF-kB

Dana Farber Cancer Institute
RFA: Compound Library Screening
Investigator: David Frank, MD, PhD
Year awarded: 2005

Selective Inhibition Of HDAC6 In The Treatment Of Multiple Myeloma

Broad Institute of Harvard and MIT
RFA: Therapeutic Targets Initiative
Investigator: James E. Bradner, MD
Year awarded: 2005

Stahmin: A Novel Target For Multiple Myeloma Therapy.

University of Arkansas for Medical Sciences
Fellows' Award
Investigator: Jin Yi Wang, MD, PhD
Year awarded: 2000

Studies Of The CXCR4/P13Kinase Pathway In Multiple Myeloma

Mayo Clinic
Fellows' Award
Investigator: Irene M. Ghobrial, MD
Year awarded: 2004

Study Of The Existence Of Abnormal IgH Chromosomal Rearrangements And At The Occurence Of Isotype-Switch Variants In The 5T Myeloma Mouse Model.

Free University, Brussels
Fellows' Award
Investigator: Marleen Bakkus, MD, PhD
Year awarded: 2000

Targeted Therapy Of Multiple Myeloma By Splice-switching Of Anti-apoptotic MCL1 To Death Inducing Forms

Dartmouth Medical School
Senior Research Award
Investigator: Ruth W. Craig, PhD
Year awarded: 2005

Targeting CD28 For The Treatment Of Multiple Myeloma

University of Miami Miller School of Medicine
RFA: Translational Research
Investigator: Kelvin Lee, MD
Year awarded: 2005

Targeting CD40 Therapy Using Humanized MAbs, Alone Or With IMiD3 In Human MM

Dana-Farber Cancer Institute
Senior Research Award
Investigator: Yu-Tzu Tai, Ph.D.
Year awarded: 2004

Targeting DKK1 In Multiple Myeloma With Humanized Anti-DKK1 Neutralizing Antibody

University of Arkansas for Medical Sciences
RFA: Translational Research
Investigator: Shmuel Yaccoby, PhD
Year awarded: 2005

Targeting ERAD And UPR In Multiple Myeloma

Center for Cancer Research, NCI-Frederick
RFA: Therapeutic Targets Initiative
Investigator: Allan M. Weissman, MD
Year awarded: 2005

Targeting Multiple Myeloma With R-Etodolac

University of California, San Diego
Senior Research Award
Investigator: Dennis Carson, MD
Year awarded: 2001

Targeting Telomere Expansion Mechanisms For Multple Myeloma

Harvard Medical School
Fellows' Award
Investigator: Masood Shammas, PhD
Year awarded: 2001

Targeting Chemoresistance In Multiple Myeloma Cells By Curcumin

University of Texas M.D. Anderson Cancer Center
Senior Research Award
Investigator: Bharat Aggarwal, PhD
Year awarded: 2003

Targeting Microenvironment Pro-survival Signals Through CD28

University of Miami
Senior Research Award
Investigator: Kelvin Lee, M.D.
Year awarded: 2004

Targeting Mitochondria To Overcome Conventional And Bortezomib/Proteasome Inhibitor PS-341 Resistance In Multiple Myeloma Cells

Dana-Farber Cancer Institute
Senior Research Award
Investigator: Dharminder Chauhan, J.D., Ph.D.
Year awarded: 2004

Targeting Multiple Myeloma By HM 1.24 Specific Measles Virus Delivered By T-cells

Julius-Maximillian Universitat Wurzburg, Germany
Senior Research Award
Investigator: Max S. Topp, MD
Year awarded: 2005

Targeting Myeloma Progenitors: Evaluation By Minimal Residual Disease As Clinical End Point In Phase II Studies Of New Treatment Modalities In Patients With Multiple Myeloma

Herlev University Hospital
Senior Research Award
Investigator: Hans Johnsen, MD, DMSc
Year awarded: 2003

The 5TMM Murine Models Of Myeloma As Tools To Study The Biology Of Multiple Myeloma - Part 1: Setup Of A Core Facility For The Maintenance Of 5TMM Models And In Vivo Experimentation

Free University of Brussels
Senior Research Award
Investigator: Karin Vanderkerken, PhD
Year awarded: 2003

The 5TMM Murine Models Of Myeloma As Tools To Study The Biology Of Multiple Myeloma - Part 2: Studies Of Myeloma Bone Disease

University of Sheffield Medical School
Senior Research Award
Investigator: Peter Croucher, PhD
Year awarded: 2003

The AKT-mTOR Pathway In Multiple Myeloma

West Los Angeles VA Hospital of the Greater Los Angeles Healthcare System
Fellows' Award
Investigator: Yijiang Shi, PhD
Year awarded: 2002

The Control Of Proliferation, Survival And Apoptosis In Multiple Myeloma

Uppsala University, Sweden
Senior Research Award
Investigator: Helena Jemberg Wiklund, PhD
Year awarded: 2000

The IGF/IGF-1R System As A Major Therapeutic Target For Myeloma

Dana-Farber Cancer Institute
Fall Senior Research Award
Investigator: Constantine S. Mitsiades, MD, PhD
Year awarded: 2002

The Molecular Chaperone Hsp90 As A Novel Therapeutic Target For Multiple Myeloma

Dana Farber Cancer Institute
Fellows' Award
Investigator: Constantine Mitsiades, MD, M.Med.Sc
Year awarded: 2001

The Role Of CDK2 In Fibronectin Induced Regulation Of P27 Levels

H. Lee Moffitt Cancer Center
Fellows' Award
Investigator: Lori A. Hazlehurst, PhD
Year awarded: 1999

The Role Of Kaposi's Sarcoma-Associated Virus In Multiple Myeloma Pathogenesis: Oncogenic And Angiogenic Potential Of Orf72 And Orf74

Dana-Farber Cancer Institute
Senior Research Award
Investigator: Noopur Raje, MD
Year awarded: 1999

The Role Of Ku86v In The Pathogenesis Of Mutliple Myeloma.

Dana-Farber Cancer Institute
Fellows' Award
Investigator: Yu-Tzu Tai, PhD
Year awarded: 2000

The Role Of MMSET In Multiple Myeloma

Weill Medical College of Cornell University
Senior Research Award
Investigator: Marta Chesi, PhD
Year awarded: 2002

The Role Of MVP/Vaults In The Generation Of Drug Resistance In Multiple Myeloma

University Hospital Rotterdam, The Netherlands
Senior Research Award
Investigator: Pieter Sonneveld, MD, PhD
Year awarded: 2001

The Role Of Macrophage Inflammatory Protein-1 Alpha In The Development Of Osteolytic Bone Lesions In Myeloma

Univ. of Texas Health Science Center at San Antonio
Fellows' Award
Investigator: Babatunde Oyajobi, PhD
Year awarded: 1999

The Role Of Proline-Rich Tyrosine Kinase PYK2 In Dexamethasone-Induced Apoptosis In Multiple Myeloma Cells

Dana-Farber Cancer Institute
Fellows' Award
Investigator: Dharminder Chauhan, PhD
Year awarded: 1998

The Role Of RANK/RANK Ligand Interaction In The Development Of Multiple Myeloma Disease: Study In The 5TMM Model

Free University Brussels
Fellows' Award
Investigator: Karin Vanderkerken, PhD
Year awarded: 2001

The Significance Of DNA Repair In Mediating Resistance Associated With Adhesion Of Myeloma Cells To Fibronectin

H. Lee Moffitt Cancer Center
Senior Research Award
Investigator: Lori Hazlehurst, PhD
Year awarded: 2001

The Immunoproteasome As A Target For Multiple Myeloma Therapy

University of North Carolina at Chapel Hill
RFA: Therapeutic Targets Initiative
Investigator: Robert Z. Orlowski, MD, PhD
Year awarded: 2005

The Incidence Of Amyloid Deposition In Abdominal And Oral Mucosal Tissue In Patients Initially Diagnosed With Multiple Myeloma

University of Pennsylvania School of Dental Medicine
Fellows' Award
Investigator: Eric T. Stoopler, BA, DMD
Year awarded: 2005

Therapeutic Effect Of Idiotype-specific CD4+ T Cells Against Multiple Myeloma

University of Oslo / Institute of Immunology
Fellows' Award
Investigator: Alexandre Corthay, MSc, PhD
Year awarded: 2005

Therapeutic Targeting Of FGFR3 Pathways In Multiple Myeloma

University of California, Irvine
Senior Research Award
Investigator: Leslie Michels Thompson, PhD
Year awarded: 2005

Therapuetic Intervention In Myeloma: FGFR3 As Drug Target

Weill Medical College of Cornell
Fellows' Award
Investigator: Suzanne Trudel, MD, MSc
Year awarded: 2002

The Role Of LIGHT/TNFSF14 And DcR3 In The Pathophysiology Of Multiple Myeloma

University of Oxford
Fellows' Award
Investigator: Claire Shipman, PhD
Year awarded: 2003

The Role Of C-maf In Multiple Myeloma

Toronto General Research Institute
Fellows' Award
Investigator: Yuan Xiao Zhu, MD
Year awarded: 2003

The Role Of Heat Shock Protein 70 (HSP70) On MM-stromal Cell Interactions

Moffitt Cancer Center
Fellows' Award
Investigator: Nimmanapalli Ramadevi, DPhil
Year awarded: 2003

The Role Of Lipid Rafts In Multiple Myeloma Pathogenesis

Dana-Farber Cancer Institute
Senior Research Award
Investigator: Klaus Podar, MD, PhD
Year awarded: 2003

The Significance Of The Unfolded Protein Response Pathway In Multiple Myeloma And Its Potential As A Therapeutic Target

Toronto General Research Institute
Fellows' Award
Investigator: Esther Masih-Khan, PhD
Year awarded: 2003

Transcriptional Functions And Targets Of The MMSET Protein Of T(4:14) Myeloma

Mount Sinai School of Medicine
Senior Research Award
Investigator: Jonathan D. Licht, MD
Year awarded: 2005

Transgenic Mouse Model Of Multiple Myeloma

Weill Medical College of Cornell University
Senior Research Award
Investigator: P. Leif Bergsagel, MD
Year awarded: 1999

Translational Network Validating The IGF-1R As A Therapeutic Target In Multiple Myeloma Models In Vitro And In Vivo

Uppsala University/Vrije Universiteit Brussel
RFA: Translational Research
Investigator: Helena Jernberg Wiklund, PhD, Karin Vanderkerken, PhD
Year awarded: 2005

Translational Control Of Apoptosis In Multiple Myeloma: Molecular Mechanisms Whereby MTOR Inhibitors Sensitize Cells To Apoptosis

West LA VA Medical Center
Fellows' Award
Investigator: Huajun Yan, PhD
Year awarded: 2004

Translational Studies Of IGFs/IGF-1R Inhibition For The Treatment Of MM

Dana-Farber Cancer Institute
Senior Research Award
Investigator: Constantine S. Mitsiades, M.D., Ph.D.
Year awarded: 2004

Treatment Of Multiple Myeloma By Antibody Mediated Immunotherapy And Induction Of Tumor Selective Antigens

Dana-Farber Cancer Institute
Fellows' Award
Investigator: Steven Peter Treon, MD
Year awarded: 1999

Tumor Vaccines For Myeloma Patients Undergoing Autologous Peripheral Blood Stem Cell Transplantation.

Johns Hopkins University School of Medicine
Senior Research Award
Investigator: Hyam I. Levitsky, MD
Year awarded: 1999

Vaccination Against Multiple Myeloma With Vaccibodies From Experimental Immunology To Patients

University of Oslo, Norway
Senior Research Award
Investigator: Bjarne Bogen, M.D., Ph.D.
Year awarded: 2004

Validation Of Melphalan-resistance Targets In Vitro In Human Mm Cell Lines Utilizing A Retroviral Based RNAi Delivery System

Van Andel Research Institute
Fellows' Award
Investigator: Jennifer Lisa Bromberg-White, BA, PhD
Year awarded: 2004

Validation Of Potential Myeloma Target Antigens For Blood Dendritic Cell Immunotherapy

Mater Medical Research Institute
Senior Research Award
Investigator: Derek Nigel John Hart, M.B, Ch.B, DPhil
Year awarded: 2004

Variants Of Ku86 Autoantigen Are Preferentially Expressed In Multiple Myeloma And Required For Malignant Transformation

Dana-Farber Cancer Institute
Fellows' Award
Investigator: Yu-Tzu Tai, PhD
Year awarded: 1998

P62ZIP And Myeloma Bone Diseases

University of Pittsburgh
Fall Senior Research Award
Investigator: G. David Roodman, MD, PhD
Year awarded: 2002

No Results Found